
OP09. GENETIC AND PHENOTYPE ANALYSIS OF FAT AUSSIE - A MOUSE MODEL OF ALSTRÖM SYDROME TODOR ARSOV1,2, Geoff Farrell2, Moira O'Bryan3, Amanda Sainsbury-Salis4, Chris Goodnow1
1. Division of Immunology and Genetics, The John Curtin School of Medical Research, Australian National University, 2. The Canberra Hospital and ANU Medical School, Canberra, 3. ARC Centre of Reproduction and Development, Monash University, Melbourne, 4. Garvan Institute of Medical Research, Sydney, AUSTRALIA
email: todor.arsov@anu.edu.au
*Corresponding Author: page: 39
|
Abstract
Until recently, primary cilia were considered relics from our skinbrain ancestors with no specific function. In the past decade it became evident that primary cilia are involved in a few fundamental physiological processes such as body energy homeostasis, body weight regulation, reproduction etc. The current understanding is that the primary cilium represents a sensory device of the cell which detects both chemical and mechanical environmental stimuli. These stimuli are then transmitted through the fine cargo intra-flagellar transport system which is linked to a few of the intracellular signalling systems. Mutations in primary cilium components result in a few human conditions, known as ciliopathies, such as Bardet-Biedl and Alström syndrome. Fat aussie is a newly identified mouse variant which inherits a mutation (foz) in the cilium component Alms1 and partially recapitulates human Alström syndrome. The phenotype includes morbid obesity followed by type 2 diabetes, steatotic liver disease and reproductive failure. We discuss specific aspects of the fat aussie phenotype such as obesity pathogenesis, spermatogenesis arrest and high fat diet induced transition of the benign steatosis to steatohepatitis in foz/foz mice. The better understanding of the role of primary cilia in body energy and body weight regulation, glucose and lipid metabolism and reproduction could pinpoint to new therapeutic targets in the treatment of some of the most prominent medical problems of our time.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|